Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey (Q24816756)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey	scientific article

Statements

instance of

scholarly article

0 references

title

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey (English)

0 references

main subject

TNF

0 references

systemic lupus erythematosus

0 references

author

Xavier Le Loët

series ordinal

3

object named as

Xavier Le Loët

0 references

Bruno Fautrel

series ordinal

5

object named as

Bruno Fautrel

0 references

Xavier Mariette

series ordinal

9

object named as

Xavier Mariette

0 references

author name string

Michel De Bandt

series ordinal

1

0 references

Jean Sibilia

series ordinal

2

0 references

Sebastian Prouzeau

series ordinal

4

0 references

Christian Marcelli

series ordinal

6

0 references

Eric Boucquillard

series ordinal

7

0 references

Jean Louis Siame

series ordinal

8

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Arthritis Research and Therapy

0 references

volume

7

0 references

issue

3

0 references

page(s)

R545-51

0 references

cites work

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

7 April 2017

Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 September 2017

Antithrombotic activity of TNF-alpha.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 September 2017

Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 September 2017

Treatment of inflammatory diseases: safety of long-term use of infliximab

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 September 2017

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 September 2017

Etanercept: therapeutic use in patients with rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 September 2017

Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

31 May 2018

Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 November 2018

Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 November 2018

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1174953

retrieved

28 November 2018

Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15899041

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15899041

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15899041

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF-alpha-induced systemic lupus syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15899041

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15899041

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of autoantibodies during prolonged treatment with infliximab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15899041

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/AR1715

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4197033

Dimensions Publication ID

1012596633

0 references

OpenCitations bibliographic resource ID

4197033

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4197033

PMC publication ID

1174953

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4197033

PubMed publication ID

15899041

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4197033

ResearchGate publication ID

7842580

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24816756&oldid=2175296745"